Cognitive Screening Made Easy for Primary Care Providers
Cognitive Screening Made Easy for Primary Care Providers
批准号:
10267188
负责人:
ROBIN C HILSABECK
金额:
$46.06万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-30 至 2023-04-30
关键词:
AddressAgeAlzheimer disease detectionAlzheimer&aposs DiseaseAssessment toolAttentionBenefits and RisksBlood PressureCaringCholesterolClinicCognitionCognitiveDementiaDevelopmentDiagnosisDiseaseEarly DiagnosisEarly identificationElderlyElectronic Health RecordFaceGoalsHealth ProfessionalImpaired cognitionIndividualInstructionInterventionKnowledgeLabelMeasurementMeasuresMedicalMedicareMemoryMethodsParticipantPatientsPhasePlayPopulationPreventive healthcarePrimary Health CareProceduresProcessRecommendationReportingResearchRisk AssessmentRoleSamplingScreening procedureShort-Term MemorySpeechSystemTestingThinkingTimeUnited StatesValidationVisitVoiceWorkcare providerscognitive abilitycognitive performancecognitive testingcostdementia riskeffectiveness testingexperiencehigh riskindexingmild cognitive impairmentpatient populationpressurepreventprimary care settingprocessing speedracial and ethnicscreeningskillstoolusability
中文摘要
项目摘要
在美国和世界各地,人们都在长寿。随着人口老龄化,人口也在老龄化
可能在记忆力、注意力、推理或其他思维能力方面有所下降的老年人人数。
如果及早发现,这些认知变化中的一些是可以治疗和逆转的。其他人可以放慢脚步
希望有一天能阻止。不幸的是,认知功能减退或非常轻微的痴呆症患者通常
直到病程后期治疗效果较差时才被认识到。作为第一个医疗保健
专业大多数人就医疗问题伸出援手,初级保健提供者在以下方面发挥关键作用
及早发现认知功能减退。虽然许多初级保健提供者在Medicare进行认知筛查
每年一次的健康访问,当患者表达担忧时,90%的人希望获得更多关于谁的信息
筛查,使用哪种评估工具,如果筛查是阳性的,应该说些什么。决定和谁一起筛选
一个简短的认知评估工具是这一过程的关键部分,因为不是每个人都需要进行筛查,而且
初级保健提供者已经面临时间压力,需要解决他们的明显和紧迫的关切
病人。该项目的长期目标是开发一种风险评估和认知筛选工具,
只需要初级保健提供者或其工作人员最少的时间和精力,并对认知能力下降敏感
来自不同教育和种族/民族背景的老年人。该工具将集成到电子产品中
健康记录系统,使初级保健提供者和患者更容易看到结果。具体目标
该项目的第一阶段是修改现有的痴呆症风险筛查指数,以识别老年人
谁是认知障碍的高危人群,开发一个简短的认知评估工具,使用以下任务
老年人容易表现,但对认知能力下降敏感,证实它们在150名患有
已经很好地定义的不同水平的认知能力,以及测试将发现整合到
电子健康记录。第二阶段的具体目标是进一步测试
新开发的工具,在250名在初级保健诊所接受护理的老年人中,找出初级保健
供应商使用该工具的程度,他们喜欢它,它是否有用和易于使用,并整合发现
进入多个电子健康记录系统。此项目的发现将填补现有工具包中的空白
初级保健提供者,并将使认知能力下降的筛查快速、容易和有效。
英文摘要
Project Summary
In the United States and around the world, people are living longer lives. As the population ages, so does the
number of older adults who may experience declines in memory, attention, reasoning, or other thinking skills.
Some of these changes in cognition can be treated and reversed if caught early. Others can be slowed down
and hopefully one day prevented. Unfortunately, people with cognitive decline or very mild dementia often are
not recognized until late in the disease course when treatments are less effective. As the first health care
professional most people reach out to about medical concerns, primary care providers play a critical role in
detecting cognitive decline early. While many primary care providers conduct cognitive screening at Medicare
Annual Wellness Visits and when patients voice concerns, 9 out of 10 would like more information about who
to screen, which assessment tool to use, and what to say if screening is positive. Deciding who to screen with
a brief cognitive assessment tool is a key part of the process because not everyone needs to be screened, and
primary care providers already face time pressures to address the obvious and immediate concerns of their
patients. The long-term goal of this project is to develop a risk assessment and cognitive screening tool that
requires minimal time and effort from primary care providers or their staff and is sensitive to cognitive decline in
older adults from diverse educational and racial/ethnic backgrounds. The tool will be integrated into electronic
health record systems to make it easy for primary care providers and patients to see results. The specific aims
of the first phase of the project are to modify an existing dementia risk screening index to identify older adults
who are at high-risk for cognitive impairment, develop a brief cognitive assessment tool using tasks that are
easy for older adults to perform yet are sensitive to cognitive decline, confirm their utility in 150 people with
varying levels of cognitive abilities that have already been well defined, and test ways to integrate findings into
the electronic health record. The specific aims for the second phase are to further test the effectiveness of the
newly developed tool in 250 older adults receiving care in a primary care clinic, to find out from primary care
providers using the tool how much they liked it and if it was useful and easy to use, and to integrate findings
into multiple electronic health record systems. Findings from this project will fill a gap in the existing toolkit of
primary care providers and will make screening for cognitive decline quick, easy, and effective.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cognitive Screening Made Easy for Primary Care Providers
-
批准号:10092711
-
项目类别:
-
资助金额:$48.42万
-
财政年份:2020
-
负责人:ROBIN C HILSABECK
-
依托单位:
RELATIONSHIP OF CYTOKINES TO COGNITIVE FUNCTIONS IN HEPATITIS C
-
批准号:7718737
-
项目类别:
-
资助金额:$0.01万
-
财政年份:2008
-
负责人:ROBIN C HILSABECK
-
依托单位:
Relationship of Cytokines to Cognitive Functions in HCV
-
批准号:7894527
-
项目类别:
-
资助金额:$16.8万
-
财政年份:2007
-
负责人:ROBIN C HILSABECK
-
依托单位:
Relationship of Cytokines to Cognitive Functions in HCV
-
批准号:7660423
-
项目类别:
-
资助金额:$16.8万
-
财政年份:2007
-
负责人:ROBIN C HILSABECK
-
依托单位:
Relationship of Cytokines to Cognitive Functions in HCV
-
批准号:7208222
-
项目类别:
-
资助金额:$16.8万
-
财政年份:2007
-
负责人:ROBIN C HILSABECK
-
依托单位:
Relationship of Cytokines to Cognitive Functions in HCV
-
批准号:8112442
-
项目类别:
-
资助金额:$16.8万
-
财政年份:2007
-
负责人:ROBIN C HILSABECK
-
依托单位:
Relationship of Cytokines to Cognitive Functions in HCV
-
批准号:7472338
-
项目类别:
-
资助金额:$16.8万
-
财政年份:2007
-
负责人:ROBIN C HILSABECK
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: